Indaptus TherapeuticsINDP
13F holders, Q1 2026 (March 31)6holders +2
4new positions
2sold out
1famous investor
$1.82avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Indaptus Therapeutics Inc. (INDP) in their 13F filings, up 2 from Q4 2025. 4 opened new positions and 2 sold out. The largest holders were Citadel Advisors ($71K), Geode Capital Management, LLC ($49K) and Morgan Stanley ($5K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Indaptus Therapeutics Inc.
- CUSIP
- 45339J204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $125K |
| Exits | 2 | $84K |
All 13F filers, Q4 2025 → Q1 2026: 68,724 shares bought and 30,288 shares sold, net +38,436 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Citadel Advisors | 0.00% | New | 39,018 | $71K |
| Geode Capital Management, LLC | 0.00% | New | 27,007 | $49K |
| Morgan Stanley | 0.00% | New | 2,697 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -40.0% | 1,890 | $3K |
| SBI Securities Co., Ltd. | 0.00% | No change | 17 | $31 |
| Cwm, LLC | 0.00% | New | 2 | $4 |
"% of holder's portfolio" is INDP's weight in each manager's 13F, not the share of Indaptus Therapeutics Inc. the manager owns.